Changes in Gyrification Over 4 Years in Bipolar Disorder and Their Association with the Brain-Derived Neurotrophic Factor Valine66 Methionine Variant

Biological Psychiatry

Volumn 66, Issue 3, 2009, Pages 293-297

  Mirakhur, Ajay ^a   Moorhead, T William J ^a   Stanfield, Andrew C ^a   McKirdy, James ^a   Sussmann, Jessika E D ^a   Hall, Jeremy ^a   Lawrie, Stephen M ^a   Johnstone, Eve C ^a   McIntosh, Andrew M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

BDNF; bipolar disorder; cohort study; gyrification; MRI

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; BRAIN DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; GRAY MATTER; HUMAN; LEFT HEMISPHERE; MALE; MENTAL PATIENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; AUTOMATIC DATA PROCESSING; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; VALINE;

EID: 67649388068     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.12.006     Document Type: Article

References (20)

1. Frazier J.A., Chiu S., Breeze J.L., Makris N., Lange N., Kennedy D.N., et al. Structural brain magnetic resonance imaging of limbic and thalamic volumes in paediatric bipolar disorder. Am J Psychiatry 162 (2005) 1256-1265
2. Drevets W.C., Price J.L., Simpson Jr. J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
3. Blumberg H.P., Krystal J.H., Bansal R., Martin A., Dziura J., Durkin K., et al. Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: A cross-sectional study. Biol Psychiatry 59 (2006) 611-618
4. Brambilla P., Harenski K., Nicoletti M., Mallinger A.G., Kupfer D.J., Frank E., et al. Differential effects of age on brain grey matter in bipolar patients and healthy individuals. Neuropsychobiology 43 (2001) 242-247
5. Farrow T.F.D., Whitford T.J., Williams L.M., Gomes L., and Harris A.W.F. Diagnosis-related regional grey matter loss over two years in first-episode schizophrenia and bipolar disorder. Biol Psychiatry 58 (2005) 713-723
6. Moorhead T.W.J., McKirdy J., Sussmann J.E.D., Hall J., Lawrie S.M., Johnstone E.C., et al. Progressive grey matter loss in patients with bipolar disorder. Biol Psychiatry 62 (2007) 894-900
7. McIntosh A.M., Moorhead T.W.J., McKirdy J., Sussmann H.J., Johnstone E.C., et al. Temporal grey matter reductions in bipolar disorder are associated with the BDNF val66met polymorphism. Mol Psychiatry 12 (2007) 902-903
8. Zilles K., Armstrong E., Schleicher A., and Kretschmann H.J. The human pattern of gyrification in the cerebral cortex. Anat Embryol (Berl) 172 (1988) 173-179
9. Sallet P.C., Elkis H., Alves T.M., Oliveira J.R., Sassi E., de Castro C.C., et al. Reduced cortical folding in schizophrenia: An MRI morphometric study. Am J Psychiatry 160 (2003) 1606-1613
10. Bonnici H.M., Moorhead T.W.J., Stanfield A.C., Harris J.M., Owens D.G.C., Johnstone E.C., et al. Prefrontal lobe gyrification index in schizophrenia, mental retardation and comorbid groups: An automated study. Neuroimage 35 (2007) 648-654
11. McGuffin P., Farmer A., and Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48 (1991) 764-770
12. First M.B., Spitzer R.L., Miriam G., and Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (2002), Biometrics Research, New York State Psychiatric Institute, New York
13. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133 (1978) 429-435
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
15. Kay S.R., Fiszbein A., and Opler L.A. The Positive and Negative Symptom Scale for Schizophrenia. Schizophr Bull 13 (1987) 261
16. Nelson H.E. National Adult Reading Test (NART): Test Manual (1982), NFER-Nelson, Windsor, UK
17. Moorhead T.W.J., Harris J.M., Stanfield A.C., Job D.E., Best J.J.K., Johnstone E.C., et al. Automated computation of the gyrification index in prefrontal lobes: Methods and comparison with manual implementation. Neuroimage 31 (2006) 1560-1566
18. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
19. Ho B.-C., Andreasen N.C., Dawson J.C., and Wassink T.H. Association between brain-derived neurotrophic factor val66met gene polymorphism and progressive brain-volume changes in schizophrenia. Am J Psychiatry 164 (2007) 1890-1899
20. Chepenik L.G., Fredericks C., Papademetris X., Spencer L., Lacadie C., Wang F., et al. Effects of the brain-derived neurotrophic factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology (2008) [published online ahead of print August 13].